Abstract
Objectives
Methods
Results
Notes
AUTHOR CONTRIBUTIONS
Conceptualization: SHB, SHK (Sung Huhn Kim). Data curation: SHK (Sang Hyun Kwak), GSN. Formal analysis: SHB. Funding acquisition: SHB. Methodology: SHB, GSN. Project administration: SHB. Visualization: SHB, SHK (Sang Hyun Kwak). Writing–original draft: SHB, SHK (Sung Huhn Kim). Writing–review & editing: SHB, SHK (Sung Huhn Kim).
ACKNOWLEDGMENTS
REFERENCES
Table 1
Table 2
Factor | Group 1 (n=9) | Group 2 (n=15) | Total (n=24) | P-value |
---|---|---|---|---|
Age (yr) | 58.56±15.69 | 61.87±17.02 | 60.63±16.26 | 0.570 |
Sex | 0.678 | |||
Male | 3 | 7 | 10 | |
Female | 6 | 8 | 14 | |
Disease durationa) | 1.000 | |||
Recent | 4 | 7 | 11 | |
Remote | 5 | 8 | 13 | |
Hypertension | 4 | 7 | 11 | 1.000 |
Diabetes mellitus | 1 | 5 | 6 | 0.351 |
cVEMP lossb) | 5 | 8 | 13 | 1.000 |
oVEMP lossb) | 6 | 12 | 18 | 0.635 |
Caloric SPVc) | 4.17±6.6 | 8.0±17 | 6.56±13.95 | 0.706 |
RCT SHA gaind) | 0.28±0.14 | 0.14±0.15 | 0.19±0.16 | 0.022* |
Average vHIT gaine) | 0.70±0.10 | 0.39±0.12 | 0.51±0.19 | <0.001* |
Values are presented as mean±standard deviation. Group 1 and group 2 included patients with preservation or loss of high-frequency VOR (LSCC gain ≥0.6 at least on one side or LSCC gain <0.6 on both sides on the vHIT), respectively.
cVEMP, cervical vestibular-evoked myogenic potential; oVEMP, ocular vestibular-evoked myogenic potential; SPV, slow-phase velocity; RCT, rotary chair test; SHA, slow harmonic acceleration; vHIT, video head impulse test; VOR, vestibulo-ocular reflex; LSCC, lateral semicircular canal.
a) Duration of disease was defined as recent if the duration of the symptoms was within 6 months and as remote if the duration of the symptoms was more than 6 months. b)cVEMP/oVEMP loss indicated bilateral “no response” in cervical or ocular vestibular-evoked myogenic potential.
c) Caloric SPV indicated the sum of the SPV of nystagmus evoked by bilateral warm and cold-water stimulation.
Table 3
Variable | Group 1 | Group 2 | Total | P-value |
---|---|---|---|---|
PTv | ||||
Change | 28.3±28.4 | −2.3±10.8 | 9.2±24.1 | 0.002* |
P-valuea) | 0.031* | 0.750 | 0.066 | |
PTc | ||||
Change | 16.3±14.8 | 5.6±9.1 | 9.6±12.4 | 0.064 |
P-valuea) | 0.016* | 0.023* | 0.001* | |
DHI total | ||||
Change | −26.3±23.8 | −10.4±17.4 | −15.7±20.6 | 0.125 |
P-valuea) | 0.047* | 0.080 | 0.006* | |
DHI physical | ||||
Change | −2.9±9.6 | 0.1±5.8 | −0.9±7.2 | 0.202 |
P-valuea) | 0.406 | 0.970 | 0.467 | |
DHI emotional | ||||
Change | −12.1±9.2 | −3.4±8.9 | −6.3±9.7 | 0.052 |
P-valuea) | 0.016* | 0.235 | 0.009* | |
DHI functional | ||||
Change | −11.3±8.9 | −5.7±6.9 | −7.6±7.9 | 0.133 |
P-valuea) | 0.031* | 0.005* | <0.001* |
Values are presented as mean±standard deviation. Group 1 and group 2 included patients with preservation or loss of high-frequency VOR (LSCC gain ≥0.6 at least on one side or LSCC gain <0.6 on both sides on the vHIT), respectively.
CDP, computerized dynamic posturography; DHI, Dizziness Handicap Inventory; PTv, vestibular score in posturography; PTc, composite score in posturography; VOR, vestibulo-ocular reflex; LSCC, lateral semicircular canal.
The Mann-Whitney U-test was used to evaluate differences between group 1 and group 2. The Wilcoxon signed-rank test was used to evaluate differences between baseline and follow-up.
Table 4
Variable | Favorable (n=6) | Unfavorable (n=18) | P-value |
---|---|---|---|
Age (yr) | 62.83±10.17 | 59.89±18.03 | 0.871 |
Sex | 0.341 | ||
Male | 1 | 9 | |
Female | 5 | 9 | |
Duration of diseasea) | 1.000 | ||
Recent | 3 | 8 | |
Remote | 3 | 10 | |
Hypertension | 0.649 | ||
Yes | 2 | 9 | |
No | 4 | 9 | |
Diabetes mellitus | 1.000 | ||
Yes | 1 | 5 | |
No | 5 | 13 | |
cVEMP | 1.000 | ||
Lossb) | 3 | 10 | |
Present | 3 | 8 | |
oVEMP | 0.139 | ||
Lossb) | 3 | 15 | |
Present | 3 | 3 | |
Caloric testc) | 1.000 | ||
Loss | 5 | 16 | |
Present | 1 | 2 | |
RCTd) | 0.066 | ||
Loss | 0 | 8 | |
Present | 6 | 10 | |
vHITe) | 0.015* | ||
Loss | 1 | 14 | |
Present | 5 | 4 |
The favorable group and unfavorable group included patients with a composite score of 70 or more and less than 70, respectively, at 6 months of follow-up.
cVEMP, cervical vestibular-evoked myogenic potential; oVEMP, ocular vestibular-evoked myogenic potential; RCT, rotary chair test; vHIT, video head impulse test.
a) Duration of disease was defined as recent if the duration of the symptoms was within 6 months and as remote if the duration of the symptoms was more than 6 months.
b) cVEMP/oVEMP loss indicated bilateral “no response” in cervical and ocular vestibular-evoked myogenic potentials.
c) Loss in the caloric test indicated that the sum of the slow phase velocity of nystagmus on each side evoked by cold and warm water stimulation was lower than 6°/sec. “Present” in the caloric test indicated that the sum of the slow-phase velocity of nystagmus evoked by cold and warm water stimulation was 6°/sec or more at least in one ear.
d) “Loss” in the RCT indicated that the gain at 0.12 Hz of slow harmonic acceleration stimulation was lower than 0.1 in the RCT. “Present” in the RCT indicated that the gain at 0.12 Hz of slow harmonic acceleration stimulation was 0.1 or more.
e) “Loss” in the vHIT indicates that the gain of the lateral semicircular canal was lower than 0.6 in both sides of the ear in the vHIT. “Present” in the vHIT indicated that the gain of the lateral semicircular canal was 0.6 or higher in one or both sides of the ear in the vHIT.